These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18661166)

  • 1. Liposomal cytarabine given concomitantly with radiotherapy in a patient with leptomeningeal metastasis from breast cancer.
    Glas M; Stuplich M; Tschampa H; Urbach H; Rasch K; Herrlinger U
    J Neurol; 2008 Nov; 255(11):1838-9. PubMed ID: 18661166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Meningeal carcinomatosis in cancer patients].
    Danova M; Invernizzi R
    Tumori; 2005; 91(5):10-21. PubMed ID: 16459648
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebrospinal fluid examination after liposomal cytarabine intrathecal injection].
    Guillaume C; Vegas H; Pastuszka A; Le Brun C; Lanotte P
    Ann Biol Clin (Paris); 2018 Oct; 76(5):568-570. PubMed ID: 30154068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liposomal cytarabine for the treatment of leptomeningeal dissemination of central nervous system tumours in children and adolescents].
    Moreno L; García Ariza MA; Cruz O; Calvo C; Fuster JL; Salinas JA; Moscardo C; Portugal R; Merino JM; Madero L
    An Pediatr (Barc); 2016 Nov; 85(5):274.e1-274.e8. PubMed ID: 27086069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
    Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
    Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report.
    Gaviani P; Silvani A; Corsini E; Erbetta A; Salmaggi A
    Neurol Sci; 2009 Jun; 30(3):251-4. PubMed ID: 19259616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of leptomeningeal malignancy.
    Pentheroudakis G; Pavlidis N
    Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis.
    Benesch M; Sovinz P; Krammer B; Lackner H; Mann G; Schwinger W; Gadner H; Urban C
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):222-6. PubMed ID: 17414563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis.
    Rueda Domínguez A; Olmos Hidalgo D; Viciana Garrido R; Torres Sánchez E
    Clin Transl Oncol; 2005 Jul; 7(6):232-8. PubMed ID: 16131445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.
    Duarte RF; Arnan M; Sánchez-Ortega I; de Llano MP; Abellán PF
    Leuk Res; 2011 Jul; 35(7):e128-30. PubMed ID: 21501870
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
    Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
    Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.
    Chamberlain MC
    J Neurooncol; 2012 Aug; 109(1):143-8. PubMed ID: 22539243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rationale for the use of liposomal cytarabine in meningeal carcinomatosis].
    Boiardi A
    Tumori; 2007; 93(3):suppl 1-3. PubMed ID: 17679478
    [No Abstract]   [Full Text] [Related]  

  • 15. Leptomeningeal metastasis in melanoma: a prospective clinical study of nine patients.
    Pape E; Desmedt E; Zairi F; Baranzelli MC; Dziwniel V; Dubois F; Bonneterre J; Mortier L; Le Rhun E
    In Vivo; 2012; 26(6):1079-86. PubMed ID: 23160697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current diagnosis and treatment of leptomeningeal metastasis.
    DeAngelis LM
    J Neurooncol; 1998; 38(2-3):245-52. PubMed ID: 9696379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium.
    Bleyer WA
    Clin Cancer Res; 1999 Nov; 5(11):3349-51. PubMed ID: 10589743
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience with the intrathecal use of liposomal cytarabine at the Besta Institute].
    Silvani A
    Tumori; 2007; 93(3):suppl 6-8. PubMed ID: 17679480
    [No Abstract]   [Full Text] [Related]  

  • 19. Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine.
    Schaefer N; Rasch K; Moehlenbruch M; Urbach H; Stuplich M; Blasius E; Scheffler B; Herrlinger U; Glas M
    Acta Oncol; 2011 Nov; 50(8):1260-2. PubMed ID: 21736503
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intrathecal chemotherapy treatment of neoplastic meningitis from solid tumors using liposomal cytarabine: experience at the Istituto Regina Elena di Roma].
    Pace A
    Tumori; 2007; 93(3):suppl 9-12. PubMed ID: 17679481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.